3I/ATLAS Threat: Harvard Expert Warns Comet Could Be 'Serial Killer'

Harvard's Avi Loeb warns that interstellar comet 3I/ATLAS could be a 'serial killer', carrying the neurotoxin hydrogen ...

Taiho Oncology Europe announces the launch of Lytgobi(R) (futibatinib) in the United Kingdom for eligible adult patients with a previously treated subtype of locally advanced ...

Lytgobi (futibatinib) marks the first medicine launched by Taiho Oncology Europe in the UK (2) For United Kingdom (UK) Trade and Medical Media Only ...
Le Lézard

Taiho Oncology Europe announces the launch of Lytgobi®? (futibatinib) in the United Kingdom for eligible adult patients with a previously treated subtype of locally advanced ...

Trade and Medical Media Only Taiho Oncology Europe GmbH announced today the UK launch of Lytgobi® (futibatinib), an irreversibly binding fibroblast growth factor receptor (FGFR) inhibitor.1,3 This ...
Scientific Research Publishing

Exploring the Efficacy of Repetitive Transcranial Magnetic Stimulation in Treating Vestibular Migraine and Its Clinical Prospects ()

Vestibular Migraine (VM) is a common clinical neurological disorder characterized by recurrent episodes of dizziness and headaches. It has a significant genetic predisposition and a high morbidity and ...
ScienceAlert on MSN

New Breakthrough to Strengthen Bone Could Reverse Osteoporosis

A recent study points to a key bone-strengthening mechanism at work in the body, which could be targeted to treat the ...
Nature

Editorial Board

Prof. David Kerr, MD, Radcliffe Department of Medicine, University of Oxford, UK Prof. Kang Zhang, PhD, Center for Biomedicine and Innovations at Faculty of Medicine, Macau University of Science and ...